Elvie

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Elvie - overview

Established

2013

Location

London, England, UK

Primary Industry

Consumer Products

About

Elvie is a pioneering company developing innovative femtech products that enhance women's health, particularly in breastfeeding solutions, aiming to provide convenience and discretion for nursing mothers. Founded in 2013 in London, UK, Elvie specializes in creating advanced breastfeeding solutions for women. The company has accomplished 7 deals, with its most recent funding round being Series C, raising GBP 12. 7 mn led by Blume Equity.


Founder Tania Boler has an extensive background in health technology, having previously worked with various health initiatives. Elvie's headquarters is in London, and it has made notable advancements in the femtech industry. Elvie offers innovative breastfeeding solutions focused on enhancing mobility and discretion for women. Its flagship products include the Elvie Pump and Elvie Stride, both wearable breast pumps equipped with smart technology.


Additionally, Elvie provides the Elvie Trainer, a smart pelvic floor exerciser. These products are tailored for nursing mothers, aiming to ease challenges during breastfeeding, particularly in professional environments, and are available in markets such as the United States, the United Kingdom, Germany, and France. In 2021, Elvie generated revenue of GBP 89. 08 mn, with an EBITDA of GBP -28.


13 mn. Revenue is driven through direct-to-consumer sales of its product range, including the Elvie Pump and various accessories, which are marketed with promotional offers to enhance customer engagement and loyalty. In March 2025, Elvie was acquired by Willow Innovations, Inc. , aiming to integrate its femtech solutions with Willow's medical device technology to enhance maternal health offerings.


The company's growth strategy includes launching new products and expanding into additional geographical markets. Funding from the recent acquisition will support these initiatives, further positioning Elvie within the maternal health market.


Current Investors

Octopus Investments, AllBright., Impact Ventures UK

Primary Industry

Consumer Products

Sub Industries

Consumer Electronics, Monitoring Equipment, Therapeutic Devices

Website

www.elvie.com/en-us

Verticals

HealthTech, Mobile Apps, Wearables & Quantified Self

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Elvie - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Elvie - financials

Fiscal Year EndedDec 31, 2019Dec 31, 2020Dec 31, 2021
Revenue (USD)---
% Revenue Growth (YoY)---
EBITDA (USD)---
Operating Income (USD)---
Operating Margin---
% EBITDA Margin---
NET Income (USD)---
% Net Margin---

Elvie - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.